(Q44867674)

7 December 2017

title

Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics (English)

1 reference

7 December 2017

0 references

1 reference

Bankole A Johnson

1

1 reference

7 December 2017

Robert M Swift

2

1 reference

7 December 2017

Nassima Ait-Daoud

3

1 reference

7 December 2017

Carlo C DiClemente

4

1 reference

7 December 2017

Martin A Javors

5

1 reference

7 December 2017

Robert J Malcolm

6

1 reference

7 December 2017

publication date

1 February 2004

1 reference

Alcoholism: Clinical and Experimental Research

7 December 2017

published in

1 reference

7 December 2017

volume

28

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

295-301

1 reference

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

The use of divalproex in alcohol relapse prevention: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Carbamazepine treatment of cocaine dependence: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Predicting treatment response to naltrexone: the influence of craving and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Fluoxetine Treatment Seems to Reduce the Beneficial Effects of Cognitive-Behavioral Therapy in Type B Alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000113409.47937.6C

10.1097/01.ALC.0000113409.47937.6C

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference